Defining protective epitopes for COVID-19 vaccination models
- PMID: 32285942
- PMCID: PMC7262208
- DOI: 10.1002/jmv.25876
Defining protective epitopes for COVID-19 vaccination models
Keywords: COVID-19; coronavirus; infection; pathology; pneumonia; vaccine.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Comment on
-
Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.J Med Virol. 2020 May;92(5):495-500. doi: 10.1002/jmv.25698. Epub 2020 Mar 3. J Med Virol. 2020. PMID: 32022276 Free PMC article.
-
Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.J Med Virol. 2020 Jun;92(6):618-631. doi: 10.1002/jmv.25736. Epub 2020 Mar 5. J Med Virol. 2020. PMID: 32108359 Free PMC article.
References
-
- Cimolai N, Taylor GP, Mah D, Morrison BJ. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol. 1992;36(5):465‐478. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical